Original paper
P3.03-047 Diagnostic Value of Secretary Leukocyte Peptide Inhibitor (SLPI) in Pleural Fluid in Malignant Pleural Mesothelioma
Abstract
There is no established diagnostic marker for malignant pleural mesothelioma (MPM). The aim of this study was to evaluate the usefulness of secretary leukocyte peptide inhibitor (SLPI) in pleural fluid for the diagnosis of MPM. The study included 52 MPM patients, 69 patients of lung cancer with pleural effusion (LC), and 50 patients with benign asbestos pleural effusion (BAPE) that were included as a control group. Pleural fluid was collected...
Paper Details
Title
P3.03-047 Diagnostic Value of Secretary Leukocyte Peptide Inhibitor (SLPI) in Pleural Fluid in Malignant Pleural Mesothelioma
Published Date
Jan 1, 2017
Journal
Volume
12
Issue
1
Pages
S1374 - S1375
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History